Internal Medicine, Hematology & Oncology · Brooklyn, NY
NPI
1063755072
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
447 Atlantic Ave
Brooklyn, NY, 11217
Phone (718) 732-4080
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
909 services
Medicare patients, 2024
292
Average age 74
Drug cost, 2024
$4.8M
1,542 prescriptions
Company payments, 2023
$2,254
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shahzaib Nabi was code 99214 (office e&m - established), 280 times for 127 patients. In total Shahzaib Nabi billed 909 services in 22 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 280 | 127 | $80.20 | $22K |
| 99233 Hospital E&M - Subsequent | Facility | 157 | 90 | $104.82 | $16K |
| 99215 Office E&M - Established | Office | 126 | 64 | $121.89 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 122 | 31 | $39.19 | $4,782 |
| 99213 Office E&M - Established | Office | 98 | 68 | $53.15 | $5,209 |
| 99223 Hospital E&M - Initial | Facility | 26 | 26 | $153.04 | $3,979 |
| 99205 Office E&M - New | Office | 20 | 20 | $146.08 | $2,922 |
| 99204 Office E&M - New | Office | 18 | 18 | $105.93 | $1,907 |
By year: 2022 $87K for 998 services; 2023 $86K for 981 services; 2024 $77K for 909 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shahzaib Nabi prescribed most often to Medicare patients was Eliquis (Apixaban), with 139 prescriptions and refills. In total Shahzaib Nabi wrote 1,542 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 139 | 157 | 23 | $88K |
| Mirtazapine Generic | 111 | 129 | 43 | $755 |
| Calcium Acetate Generic | 108 | 161 | 19 | $1,012 |
| Anastrozole Generic | 106 | 291 | 32 | $1,747 |
| Xarelto Rivaroxaban | 65 | 99 | 12 | $54K |
| Abiraterone Acetate Generic | 61 | 61 | Under 11 | $168K |
| Folic Acid Generic | 55 | 125 | 19 | $91.4 |
| Letrozole Generic | 55 | 143 | 13 | $697 |
| Ondansetron Odt Ondansetron | 41 | 43 | 35 | $906 |
| Prednisone Generic | 41 | 71 | 13 | $133 |
| Hydroxyurea Generic | 39 | 74 | Under 11 | $1,615 |
| Gabapentin Generic | 32 | 64 | 14 | $158 |
| Acyclovir Generic | 31 | 39 | Under 11 | $190 |
| Tamoxifen Citrate Generic | 30 | 62 | Under 11 | $935 |
| Tavalisse Fostamatinib Disodium | 30 | 30 | Under 11 | $446K |
Brand drugs: - claims; generic drugs: 948 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Shahzaib Nabi $2,254 ($2,254 in general payments such as food, travel and fees) from 4 companies. The largest payer was Janssen Biotech, Inc. with $1,363.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.